Intense Pulsed Light in Meibomian Gland Dysfunctions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

45 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-25

Study Completion Date

2020-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dry eye disease (DED) is an extremely common disease whose meibomian gland dysfunction is the main etiology.

Polychromatic intense pulsed light (IPL) is a promising new therapeutic alternative but few clinical data have been published.

A new IPL device has recently been marketed: LACRYSTIM (QUANTEL, France). The investigators have been using it in our clinical practice since June 2019.

The investigators present a retrospective study on our first clinical results.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effectiveness and Safety of Intense Pulsed Light in Patients With Meibomian Gland Dysfunction

NCT03518398

Meibomian Gland Dysfunction (Disorder) Dry Eye Syndromes

COMPLETED PHASE3

Intense Pulsed Light in Meibomian Gland Dysfunction

NCT05089591

Meibomian Gland Dysfunction

UNKNOWN NA

Effectiveness of Intense Pulsed Light for Improving Dry Eye Syndrome

NCT03396913

Dry Eye Syndrome

COMPLETED NA

IPL and MGX Versus MGX Alone in the Treatment of Dry Eye Disease Secondary to MGD

NCT03265652

Dry Eye Meibomian Gland Dysfunction

COMPLETED NA

Mechanisms of Light-based Therapies for Dry Eye Disease

NCT06004895

Dry Eye Syndromes Meibomian Gland Dysfunction

ACTIVE_NOT_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye Syndromes Meibomian Gland Dysfunction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with dry eye disease with meibomian gland dysfunction

Collected data from patient records for consultations Day 0, Day 15 and Day 45 (3 treatment sessions) and Months 3, Months 6 (follow-up consultations).

\- parameters used for each treatment session: duration of treatment session and intensity of intense pulsed light

intense pulsed light (usual practice)

Intervention Type DEVICE

collection data : parameters used for each treatment session: duration of treatment session and intensity of intense pulsed light

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intense pulsed light (usual practice)

collection data : parameters used for each treatment session: duration of treatment session and intensity of intense pulsed light

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with Dry eye disease with meibomian gland dysfunction, preferentially mild to moderate, and having benefited from intense pulsed light treatment.
* patient affiliated with a social security organization